Article
Genetic variability of the forkhead box O3 and prostate cancer risk in the European Prospective Investigation on Cancer.
Oncology reports - 1 Oct 2011
Campa Daniele, Hüsing Anika, Dostal Lucie, Stein Angelika, Drogan Dagmar, Boeing Heiner, Tjønneland Anne, Roswall Nina, Østergaard Jane Nautrup, Overvad Kim, Rodríguez Laudina, Bonet Catalina, Sánchez Maria-José, Larrañaga Nerea, Huerta José María, Ardanaz Eva, Khaw Kay-Tee, Wareham Nicholas, Travis Ruth C, Allen Naomi E, Trichopoulou Antonia, Zylis Dimosthenis, Karapetyan Tina, Palli Domenico, Sieri Sabina, Tumino Rosario, Vineis Paolo, Bueno-de-Mesquita H Bas, Lenner Per, Johansson Mattias, Jenab Mazda, Cox David, Siddiq Afshan, Kaaks Rudolf, Canzian Federico
Abstract excerpt
Forkhead box O3 (FOXO3) has a wide range of functions: it promotes tumor suppression, cell cycle arrest, repair of damaged DNA, detoxification of reactive oxygen species, apoptosis and plays a pivotal role in promoting longevity. FOXO3 is a key downstream target of the PI3K-Akt pathway in response to cellular stimulation by growth factors or insulin and has been proposed as a bridge between ageing and tumor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
